You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 March 2026 - Clinical-stage biotechnology company Synnovation Therapeutics LLC announced on Friday that Swiss pharmaceutical company Novartis AG (SIX:NOVN) (NYSE:NVS) has agreed to acquire Pikavation Therapeutics, a subsidiary of Synnovation, incl...
20 March 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Friday that it has signed a contract with Australian biopharmaceutical company Telix Pharmaceuticals Limited (ASX:TLX, NASD...
20 March 2026 - Bambusa Therapeutics Inc, a clinical-stage biotechnology company developing next-generation bispecific antibodies for immunology and inflammation (I&I), announced on Thursday the appointment of Todd James as executive vice preside...
20 March 2026 - Collegium Pharmaceutical Inc (Nasdaq:COLL) and Corium Therapeutics Holdings LLC announced on Thursday a definitive agreement for Collegium to acquire AZSTARYS for USD650m in cash with the potential for additional milestone payments up...
20 March 2026 - Humacyte Inc (Nasdaq:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, announced on Thursday that it has entered into a securities purchase ag...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe